Harpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 150 points on Monday.

Shares of Harpoon Therapeutics, Inc.(NASDAQ:HARP) rose sharply in pre-market trading. Bloomberg reported that Merck is in advanced talks to buy Harpoon Therapeutics for $23 per share.

Harpoon Therapeutics shares jumped 98.6% to $20.95 in pre-market trading.

Here are some big stocks recording gains in today’s pre-market trading session.

• Heron Therapeutics, Inc. (NASDAQ:HRTX) shares rose 14.1% to $2.02 in pre-market trading. Heron Therapeutics announced a five-year distribution partnership with CrossLink Life Sciences to expand promotional effort for ZYNRELEF.
• Better Home & Finance Holding Company (NASDAQ:BETR) surged 11.2% to $0.7470 in pre-market trading.
• Sabre Corporation (NASDAQ:SABR) climbed 5.1% to $4.57 in pre-market trading.
• Cronos Group Inc. (NASDAQ:CRON) gained 4.1% to $2.27 in pre-market trading after gaining over 2% on Friday.
• Nextracker Inc. (NASDAQ:NXT) climbed 4% to $43.65 in pre-market trading.
• Upwork Inc. (NASDAQ:UPWK) rose 3.6% to $14.55 in pre-market trading.
• Altimmune, Inc. (NASDAQ:ALT) gained 3.2% to $11.55 in pre-market trading after declining around 4% on Friday.
• Annexon, Inc. (NASDAQ:ANNX) gained 3.2% to $4.78 in pre-market trading. Annexon outlined its 2024 priorities with late-stage clinical milestones across upstream complement portfolio for autoimmune, ophthalmic and neurodegenerative diseases.

Now Read This: How To Earn $500 A Month From Conagra Brands Stock Following Latest Earnings Report

Don’t forget to check out our premarket coverage here